nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFA4L2—mammalian vulva—skin cancer	0.00191	0.00355	CbGeAlD
Metformin—ND4—skin of body—skin cancer	0.0019	0.00354	CbGeAlD
Metformin—NDUFC2—nipple—skin cancer	0.0019	0.00354	CbGeAlD
Metformin—NDUFC2—neck—skin cancer	0.00188	0.0035	CbGeAlD
Metformin—NDUFV3—head—skin cancer	0.00185	0.00345	CbGeAlD
Metformin—NDUFA5—connective tissue—skin cancer	0.00185	0.00343	CbGeAlD
Metformin—NDUFAF4—connective tissue—skin cancer	0.00183	0.00341	CbGeAlD
Metformin—NDUFS2—nipple—skin cancer	0.00183	0.0034	CbGeAlD
Metformin—NDUFA9—lymphoid tissue—skin cancer	0.00182	0.00339	CbGeAlD
Metformin—NDUFS1—connective tissue—skin cancer	0.00182	0.00338	CbGeAlD
Metformin—NDUFS3—nipple—skin cancer	0.00181	0.00336	CbGeAlD
Metformin—NDUFB10—connective tissue—skin cancer	0.00181	0.00336	CbGeAlD
Metformin—NDUFS6—head—skin cancer	0.0018	0.00335	CbGeAlD
Metformin—NDUFA1—lymphoid tissue—skin cancer	0.0018	0.00334	CbGeAlD
Metformin—NDUFA10—skin of body—skin cancer	0.00178	0.00331	CbGeAlD
Metformin—NDUFC1—skin of body—skin cancer	0.00176	0.00328	CbGeAlD
Metformin—NDUFA9—female reproductive system—skin cancer	0.00176	0.00327	CbGeAlD
Metformin—NDUFA13—female reproductive system—skin cancer	0.00176	0.00327	CbGeAlD
Metformin—NDUFA6—connective tissue—skin cancer	0.00176	0.00327	CbGeAlD
Metformin—NDUFS4—connective tissue—skin cancer	0.00175	0.00325	CbGeAlD
Metformin—NDUFV2—lymphoid tissue—skin cancer	0.00174	0.00324	CbGeAlD
Metformin—NDUFA1—female reproductive system—skin cancer	0.00173	0.00322	CbGeAlD
Metformin—NDUFB4—connective tissue—skin cancer	0.00172	0.0032	CbGeAlD
Metformin—ND6—skin of body—skin cancer	0.00172	0.0032	CbGeAlD
Metformin—NDUFAB1—connective tissue—skin cancer	0.00171	0.00318	CbGeAlD
Metformin—NDUFA12—epithelium—skin cancer	0.0017	0.00317	CbGeAlD
Metformin—NDUFB9—connective tissue—skin cancer	0.0017	0.00316	CbGeAlD
Metformin—NDUFV1—connective tissue—skin cancer	0.00168	0.00313	CbGeAlD
Metformin—NDUFV2—female reproductive system—skin cancer	0.00168	0.00313	CbGeAlD
Metformin—SLC29A4—head—skin cancer	0.00168	0.00312	CbGeAlD
Metformin—NDUFS5—connective tissue—skin cancer	0.00167	0.00311	CbGeAlD
Metformin—NDUFB8—connective tissue—skin cancer	0.00167	0.00311	CbGeAlD
Metformin—NDUFA5—skin of body—skin cancer	0.00167	0.0031	CbGeAlD
Metformin—NDUFB6—skin of body—skin cancer	0.00165	0.00308	CbGeAlD
Metformin—NDUFS1—skin of body—skin cancer	0.00164	0.00305	CbGeAlD
Metformin—NDUFAF3—head—skin cancer	0.00164	0.00305	CbGeAlD
Metformin—NDUFA4L2—female reproductive system—skin cancer	0.00164	0.00304	CbGeAlD
Metformin—NDUFB10—skin of body—skin cancer	0.00163	0.00303	CbGeAlD
Metformin—NDUFAB1—epithelium—skin cancer	0.00163	0.00302	CbGeAlD
Metformin—NDUFB9—epithelium—skin cancer	0.00162	0.003	CbGeAlD
Metformin—NDUFC1—mammalian vulva—skin cancer	0.00161	0.00299	CbGeAlD
Metformin—ND4L—lymphoid tissue—skin cancer	0.00159	0.00296	CbGeAlD
Metformin—ND5—lymphoid tissue—skin cancer	0.00159	0.00296	CbGeAlD
Metformin—ND3—lymphoid tissue—skin cancer	0.00159	0.00296	CbGeAlD
Metformin—ND2—lymphoid tissue—skin cancer	0.00159	0.00296	CbGeAlD
Metformin—NDUFS5—epithelium—skin cancer	0.00159	0.00295	CbGeAlD
Metformin—NDUFB5—skin of body—skin cancer	0.00159	0.00295	CbGeAlD
Metformin—NDUFAF1—mammalian vulva—skin cancer	0.00158	0.00294	CbGeAlD
Metformin—NDUFS7—connective tissue—skin cancer	0.00157	0.00291	CbGeAlD
Metformin—NDUFAF2—mammalian vulva—skin cancer	0.00156	0.00289	CbGeAlD
Metformin—NDUFB3—mammalian vulva—skin cancer	0.00156	0.00289	CbGeAlD
Metformin—NDUFAB1—skin of body—skin cancer	0.00155	0.00288	CbGeAlD
Metformin—ND4—lymphoid tissue—skin cancer	0.00154	0.00287	CbGeAlD
Metformin—ND4L—female reproductive system—skin cancer	0.00154	0.00286	CbGeAlD
Metformin—ND3—female reproductive system—skin cancer	0.00154	0.00286	CbGeAlD
Metformin—ND2—female reproductive system—skin cancer	0.00154	0.00286	CbGeAlD
Metformin—ND5—female reproductive system—skin cancer	0.00154	0.00286	CbGeAlD
Metformin—NDUFB9—skin of body—skin cancer	0.00154	0.00286	CbGeAlD
Metformin—NDUFA4—skin of body—skin cancer	0.00153	0.00284	CbGeAlD
Metformin—NDUFA5—mammalian vulva—skin cancer	0.00152	0.00283	CbGeAlD
Metformin—NDUFV1—skin of body—skin cancer	0.00152	0.00282	CbGeAlD
Metformin—NDUFA2—lymphoid tissue—skin cancer	0.00151	0.00281	CbGeAlD
Metformin—NDUFAF4—mammalian vulva—skin cancer	0.00151	0.00281	CbGeAlD
Metformin—NDUFB6—mammalian vulva—skin cancer	0.00151	0.00281	CbGeAlD
Metformin—NDUFB8—skin of body—skin cancer	0.00151	0.00281	CbGeAlD
Metformin—NDUFS5—skin of body—skin cancer	0.00151	0.00281	CbGeAlD
Metformin—ND4—female reproductive system—skin cancer	0.00149	0.00277	CbGeAlD
Metformin—NDUFB10—mammalian vulva—skin cancer	0.00149	0.00277	CbGeAlD
Metformin—ND1—neck—skin cancer	0.00149	0.00276	CbGeAlD
Metformin—NDUFA12—mammalian vulva—skin cancer	0.00148	0.00275	CbGeAlD
Metformin—NDUFB7—mammalian vulva—skin cancer	0.00148	0.00275	CbGeAlD
Metformin—NDUFA9—head—skin cancer	0.00147	0.00273	CbGeAlD
Metformin—NDUFA13—head—skin cancer	0.00147	0.00273	CbGeAlD
Metformin—NDUFS8—mammalian vulva—skin cancer	0.00147	0.00273	CbGeAlD
Metformin—NDUFB1—mammalian vulva—skin cancer	0.00147	0.00273	CbGeAlD
Metformin—NDUFA2—female reproductive system—skin cancer	0.00146	0.00271	CbGeAlD
Metformin—NDUFB5—mammalian vulva—skin cancer	0.00145	0.00269	CbGeAlD
Metformin—NDUFA6—mammalian vulva—skin cancer	0.00145	0.00269	CbGeAlD
Metformin—NDUFA1—head—skin cancer	0.00145	0.00269	CbGeAlD
Metformin—NDUFA10—lymphoid tissue—skin cancer	0.00144	0.00268	CbGeAlD
Metformin—NDUFS4—mammalian vulva—skin cancer	0.00144	0.00267	CbGeAlD
Metformin—NDUFB4—mammalian vulva—skin cancer	0.00142	0.00264	CbGeAlD
Metformin—NDUFB2—lymphoid tissue—skin cancer	0.00142	0.00263	CbGeAlD
Metformin—NDUFAB1—mammalian vulva—skin cancer	0.00141	0.00262	CbGeAlD
Metformin—NDUFV2—head—skin cancer	0.0014	0.00261	CbGeAlD
Metformin—NDUFA8—mammalian vulva—skin cancer	0.0014	0.00261	CbGeAlD
Metformin—NDUFB9—mammalian vulva—skin cancer	0.0014	0.00261	CbGeAlD
Metformin—ND6—lymphoid tissue—skin cancer	0.00139	0.00259	CbGeAlD
Metformin—NDUFA4—mammalian vulva—skin cancer	0.00139	0.00259	CbGeAlD
Metformin—NDUFA10—female reproductive system—skin cancer	0.00139	0.00259	CbGeAlD
Metformin—NDUFB11—mammalian vulva—skin cancer	0.00138	0.00257	CbGeAlD
Metformin—NDUFV1—mammalian vulva—skin cancer	0.00138	0.00257	CbGeAlD
Metformin—NDUFB8—mammalian vulva—skin cancer	0.00138	0.00256	CbGeAlD
Metformin—NDUFS5—mammalian vulva—skin cancer	0.00138	0.00256	CbGeAlD
Metformin—NDUFB2—female reproductive system—skin cancer	0.00137	0.00254	CbGeAlD
Metformin—NDUFAF1—female reproductive system—skin cancer	0.00135	0.00252	CbGeAlD
Metformin—NDUFA5—lymphoid tissue—skin cancer	0.00135	0.00251	CbGeAlD
Metformin—ND6—female reproductive system—skin cancer	0.00134	0.0025	CbGeAlD
Metformin—NDUFB3—female reproductive system—skin cancer	0.00133	0.00248	CbGeAlD
Metformin—NDUFS1—lymphoid tissue—skin cancer	0.00133	0.00247	CbGeAlD
Metformin—NDUFB10—lymphoid tissue—skin cancer	0.00132	0.00246	CbGeAlD
Metformin—NDUFA12—lymphoid tissue—skin cancer	0.00131	0.00244	CbGeAlD
Metformin—NDUFB1—lymphoid tissue—skin cancer	0.0013	0.00242	CbGeAlD
Metformin—NDUFA11—female reproductive system—skin cancer	0.0013	0.00242	CbGeAlD
Metformin—NDUFA5—female reproductive system—skin cancer	0.0013	0.00242	CbGeAlD
Metformin—NDUFS2—connective tissue—skin cancer	0.0013	0.00241	CbGeAlD
Metformin—NDUFAF4—female reproductive system—skin cancer	0.00129	0.0024	CbGeAlD
Metformin—NDUFB6—female reproductive system—skin cancer	0.00129	0.0024	CbGeAlD
Metformin—NDUFA6—lymphoid tissue—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—ND3—head—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—ND5—head—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—ND4L—head—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—ND2—head—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—NDUFS1—female reproductive system—skin cancer	0.00128	0.00239	CbGeAlD
Metformin—NDUFS3—connective tissue—skin cancer	0.00128	0.00238	CbGeAlD
Metformin—NDUFC2—epithelium—skin cancer	0.00128	0.00238	CbGeAlD
Metformin—NDUFS4—lymphoid tissue—skin cancer	0.00128	0.00237	CbGeAlD
Metformin—NDUFB10—female reproductive system—skin cancer	0.00127	0.00237	CbGeAlD
Metformin—NDUFA12—female reproductive system—skin cancer	0.00126	0.00235	CbGeAlD
Metformin—NDUFB7—female reproductive system—skin cancer	0.00126	0.00235	CbGeAlD
Metformin—NDUFB4—lymphoid tissue—skin cancer	0.00126	0.00234	CbGeAlD
Metformin—NDUFS8—female reproductive system—skin cancer	0.00126	0.00234	CbGeAlD
Metformin—NDUFAB1—lymphoid tissue—skin cancer	0.00125	0.00233	CbGeAlD
Metformin—NDUFA8—lymphoid tissue—skin cancer	0.00124	0.00231	CbGeAlD
Metformin—NDUFB9—lymphoid tissue—skin cancer	0.00124	0.00231	CbGeAlD
Metformin—ND4—head—skin cancer	0.00124	0.00231	CbGeAlD
Metformin—NDUFB5—female reproductive system—skin cancer	0.00124	0.0023	CbGeAlD
Metformin—NDUFA6—female reproductive system—skin cancer	0.00124	0.0023	CbGeAlD
Metformin—NDUFA4—lymphoid tissue—skin cancer	0.00124	0.0023	CbGeAlD
Metformin—NDUFS4—female reproductive system—skin cancer	0.00123	0.00229	CbGeAlD
Metformin—NDUFA7—lymph node—skin cancer	0.00123	0.00229	CbGeAlD
Metformin—NDUFV1—lymphoid tissue—skin cancer	0.00123	0.00229	CbGeAlD
Metformin—NDUFB11—lymphoid tissue—skin cancer	0.00123	0.00229	CbGeAlD
Metformin—NDUFS5—lymphoid tissue—skin cancer	0.00122	0.00227	CbGeAlD
Metformin—NDUFB8—lymphoid tissue—skin cancer	0.00122	0.00227	CbGeAlD
Metformin—NDUFB4—female reproductive system—skin cancer	0.00122	0.00226	CbGeAlD
Metformin—NDUFAB1—female reproductive system—skin cancer	0.00121	0.00225	CbGeAlD
Metformin—NDUFA8—female reproductive system—skin cancer	0.0012	0.00223	CbGeAlD
Metformin—NDUFB9—female reproductive system—skin cancer	0.0012	0.00223	CbGeAlD
Metformin—NDUFA4—female reproductive system—skin cancer	0.00119	0.00222	CbGeAlD
Metformin—NDUFV1—female reproductive system—skin cancer	0.00119	0.0022	CbGeAlD
Metformin—NDUFB11—female reproductive system—skin cancer	0.00119	0.0022	CbGeAlD
Metformin—PRKAB1—mammalian vulva—skin cancer	0.00118	0.00219	CbGeAlD
Metformin—NDUFS5—female reproductive system—skin cancer	0.00118	0.00219	CbGeAlD
Metformin—NDUFB8—female reproductive system—skin cancer	0.00118	0.00219	CbGeAlD
Metformin—NDUFS2—skin of body—skin cancer	0.00117	0.00218	CbGeAlD
Metformin—NDUFA10—head—skin cancer	0.00116	0.00216	CbGeAlD
Metformin—NDUFS3—skin of body—skin cancer	0.00116	0.00215	CbGeAlD
Metformin—NDUFC1—head—skin cancer	0.00115	0.00214	CbGeAlD
Metformin—NDUFB2—head—skin cancer	0.00114	0.00212	CbGeAlD
Metformin—NDUFAF1—head—skin cancer	0.00113	0.0021	CbGeAlD
Metformin—ND6—head—skin cancer	0.00112	0.00209	CbGeAlD
Metformin—NDUFAF2—head—skin cancer	0.00111	0.00207	CbGeAlD
Metformin—NDUFC2—mammalian vulva—skin cancer	0.00111	0.00207	CbGeAlD
Metformin—NDUFS7—female reproductive system—skin cancer	0.0011	0.00205	CbGeAlD
Metformin—NDUFA5—head—skin cancer	0.00109	0.00202	CbGeAlD
Metformin—NDUFA11—head—skin cancer	0.00109	0.00202	CbGeAlD
Metformin—Nasopharyngitis—Fluorouracil—skin cancer	0.00108	0.00282	CcSEcCtD
Metformin—Constipation—Vemurafenib—skin cancer	0.00108	0.00281	CcSEcCtD
Metformin—NDUFAF4—head—skin cancer	0.00108	0.00201	CbGeAlD
Metformin—NDUFB6—head—skin cancer	0.00108	0.00201	CbGeAlD
Metformin—Oedema—Imiquimod—skin cancer	0.00108	0.00281	CcSEcCtD
Metformin—Lightheadedness—Docetaxel—skin cancer	0.00108	0.00281	CcSEcCtD
Metformin—Hypoaesthesia—Bleomycin—skin cancer	0.00107	0.00279	CcSEcCtD
Metformin—NDUFS1—head—skin cancer	0.00107	0.00199	CbGeAlD
Metformin—Infection—Imiquimod—skin cancer	0.00107	0.00279	CcSEcCtD
Metformin—NDUFS2—mammalian vulva—skin cancer	0.00107	0.00199	CbGeAlD
Metformin—NDUFB10—head—skin cancer	0.00106	0.00198	CbGeAlD
Metformin—Neutropenia—Temozolomide—skin cancer	0.00106	0.00277	CcSEcCtD
Metformin—Shock—Imiquimod—skin cancer	0.00106	0.00276	CcSEcCtD
Metformin—Nervous system disorder—Imiquimod—skin cancer	0.00106	0.00275	CcSEcCtD
Metformin—NDUFA12—head—skin cancer	0.00106	0.00197	CbGeAlD
Metformin—NDUFB7—head—skin cancer	0.00106	0.00197	CbGeAlD
Metformin—Upper respiratory tract infection—Temozolomide—skin cancer	0.00106	0.00275	CcSEcCtD
Metformin—NDUFS3—mammalian vulva—skin cancer	0.00106	0.00196	CbGeAlD
Metformin—NDUFS8—head—skin cancer	0.00105	0.00195	CbGeAlD
Metformin—NDUFB1—head—skin cancer	0.00105	0.00195	CbGeAlD
Metformin—Skin disorder—Imiquimod—skin cancer	0.00105	0.00273	CcSEcCtD
Metformin—Hyperhidrosis—Imiquimod—skin cancer	0.00104	0.00271	CcSEcCtD
Metformin—NDUFA6—head—skin cancer	0.00104	0.00193	CbGeAlD
Metformin—NDUFB5—head—skin cancer	0.00104	0.00193	CbGeAlD
Metformin—NDUFS4—head—skin cancer	0.00103	0.00191	CbGeAlD
Metformin—Anorexia—Imiquimod—skin cancer	0.00103	0.00268	CcSEcCtD
Metformin—Angina pectoris—Fluorouracil—skin cancer	0.00102	0.00265	CcSEcCtD
Metformin—SLC47A1—nipple—skin cancer	0.00102	0.0019	CbGeAlD
Metformin—NDUFB4—head—skin cancer	0.00102	0.00189	CbGeAlD
Metformin—Infestation—Temozolomide—skin cancer	0.00101	0.00264	CcSEcCtD
Metformin—Infestation NOS—Temozolomide—skin cancer	0.00101	0.00264	CcSEcCtD
Metformin—PRKAB1—female reproductive system—skin cancer	0.00101	0.00188	CbGeAlD
Metformin—NDUFAB1—head—skin cancer	0.00101	0.00188	CbGeAlD
Metformin—Hepatitis—Dactinomycin—skin cancer	0.00101	0.00262	CcSEcCtD
Metformin—NDUFB9—head—skin cancer	0.001	0.00186	CbGeAlD
Metformin—NDUFA8—head—skin cancer	0.001	0.00186	CbGeAlD
Metformin—Flushing—Bleomycin—skin cancer	0.001	0.00261	CcSEcCtD
Metformin—NDUFA4—head—skin cancer	0.000997	0.00185	CbGeAlD
Metformin—Neuropathy peripheral—Temozolomide—skin cancer	0.000994	0.00259	CcSEcCtD
Metformin—NDUFB11—head—skin cancer	0.000991	0.00184	CbGeAlD
Metformin—NDUFV1—head—skin cancer	0.000991	0.00184	CbGeAlD
Metformin—NDUFC2—lymphoid tissue—skin cancer	0.000987	0.00184	CbGeAlD
Metformin—NDUFS5—head—skin cancer	0.000985	0.00183	CbGeAlD
Metformin—NDUFB8—head—skin cancer	0.000985	0.00183	CbGeAlD
Metformin—NDUFV2—lymph node—skin cancer	0.000983	0.00183	CbGeAlD
Metformin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000983	0.00256	CcSEcCtD
Metformin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000974	0.00253	CcSEcCtD
Metformin—Paraesthesia—Imiquimod—skin cancer	0.000969	0.00252	CcSEcCtD
Metformin—Chills—Bleomycin—skin cancer	0.000968	0.00252	CcSEcCtD
Metformin—Dyspnoea—Imiquimod—skin cancer	0.000962	0.0025	CcSEcCtD
Metformin—ND1—skin of body—skin cancer	0.000961	0.00179	CbGeAlD
Metformin—Somnolence—Imiquimod—skin cancer	0.000959	0.0025	CcSEcCtD
Metformin—Hepatobiliary disease—Temozolomide—skin cancer	0.000959	0.00249	CcSEcCtD
Metformin—NDUFA4L2—lymph node—skin cancer	0.000957	0.00178	CbGeAlD
Metformin—NDUFC2—female reproductive system—skin cancer	0.000952	0.00177	CbGeAlD
Metformin—Dyspepsia—Imiquimod—skin cancer	0.00095	0.00247	CcSEcCtD
Metformin—NDUFS2—lymphoid tissue—skin cancer	0.000949	0.00176	CbGeAlD
Metformin—Erythema—Bleomycin—skin cancer	0.000939	0.00244	CcSEcCtD
Metformin—Decreased appetite—Imiquimod—skin cancer	0.000938	0.00244	CcSEcCtD
Metformin—NDUFS3—lymphoid tissue—skin cancer	0.000937	0.00174	CbGeAlD
Metformin—Infestation—Fluorouracil—skin cancer	0.000934	0.00243	CcSEcCtD
Metformin—Infestation NOS—Fluorouracil—skin cancer	0.000934	0.00243	CcSEcCtD
Metformin—Flushing—Dactinomycin—skin cancer	0.000934	0.00243	CcSEcCtD
Metformin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000931	0.00242	CcSEcCtD
Metformin—Fatigue—Imiquimod—skin cancer	0.00093	0.00242	CcSEcCtD
Metformin—NDUFS7—head—skin cancer	0.000923	0.00172	CbGeAlD
Metformin—Renal impairment—Docetaxel—skin cancer	0.000919	0.00239	CcSEcCtD
Metformin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000916	0.00238	CcSEcCtD
Metformin—NDUFS2—female reproductive system—skin cancer	0.000915	0.0017	CbGeAlD
Metformin—Hepatitis—Temozolomide—skin cancer	0.00091	0.00237	CcSEcCtD
Metformin—Asthenia—Vemurafenib—skin cancer	0.000908	0.00236	CcSEcCtD
Metformin—Hypoaesthesia—Temozolomide—skin cancer	0.000905	0.00236	CcSEcCtD
Metformin—NDUFS3—female reproductive system—skin cancer	0.000904	0.00168	CbGeAlD
Metformin—Chills—Dactinomycin—skin cancer	0.000903	0.00235	CcSEcCtD
Metformin—ND2—lymph node—skin cancer	0.000899	0.00167	CbGeAlD
Metformin—ND3—lymph node—skin cancer	0.000899	0.00167	CbGeAlD
Metformin—ND5—lymph node—skin cancer	0.000899	0.00167	CbGeAlD
Metformin—ND4L—lymph node—skin cancer	0.000899	0.00167	CbGeAlD
Metformin—Oedema peripheral—Temozolomide—skin cancer	0.000896	0.00233	CcSEcCtD
Metformin—Pruritus—Vemurafenib—skin cancer	0.000895	0.00233	CcSEcCtD
Metformin—Connective tissue disorder—Temozolomide—skin cancer	0.000894	0.00233	CcSEcCtD
Metformin—Lethargy—Docetaxel—skin cancer	0.000893	0.00232	CcSEcCtD
Metformin—Feeling abnormal—Imiquimod—skin cancer	0.000889	0.00231	CcSEcCtD
Metformin—Gastrointestinal pain—Imiquimod—skin cancer	0.000882	0.0023	CcSEcCtD
Metformin—Erythema—Dactinomycin—skin cancer	0.000876	0.00228	CcSEcCtD
Metformin—Pain in extremity—Docetaxel—skin cancer	0.000875	0.00228	CcSEcCtD
Metformin—Ill-defined disorder—Bleomycin—skin cancer	0.000871	0.00227	CcSEcCtD
Metformin—ND4—lymph node—skin cancer	0.00087	0.00162	CbGeAlD
Metformin—Diarrhoea—Vemurafenib—skin cancer	0.000866	0.00225	CcSEcCtD
Metformin—Migraine—Docetaxel—skin cancer	0.000861	0.00224	CcSEcCtD
Metformin—Urticaria—Imiquimod—skin cancer	0.000857	0.00223	CcSEcCtD
Metformin—Abdominal pain—Imiquimod—skin cancer	0.000853	0.00222	CcSEcCtD
Metformin—NDUFA2—lymph node—skin cancer	0.000853	0.00159	CbGeAlD
Metformin—Eye disorder—Temozolomide—skin cancer	0.00085	0.00221	CcSEcCtD
Metformin—Malaise—Bleomycin—skin cancer	0.000847	0.0022	CcSEcCtD
Metformin—Flushing—Temozolomide—skin cancer	0.000845	0.0022	CcSEcCtD
Metformin—Cardiac disorder—Temozolomide—skin cancer	0.000845	0.0022	CcSEcCtD
Metformin—PRKAB1—head—skin cancer	0.000844	0.00157	CbGeAlD
Metformin—Rhinitis—Fluorouracil—skin cancer	0.000841	0.00219	CcSEcCtD
Metformin—Dizziness—Vemurafenib—skin cancer	0.000837	0.00218	CcSEcCtD
Metformin—Hypoaesthesia—Fluorouracil—skin cancer	0.000834	0.00217	CcSEcCtD
Metformin—Angiopathy—Temozolomide—skin cancer	0.000826	0.00215	CcSEcCtD
Metformin—Immune system disorder—Temozolomide—skin cancer	0.000822	0.00214	CcSEcCtD
Metformin—Mediastinal disorder—Temozolomide—skin cancer	0.00082	0.00213	CcSEcCtD
Metformin—Chills—Temozolomide—skin cancer	0.000817	0.00212	CcSEcCtD
Metformin—Dehydration—Docetaxel—skin cancer	0.000814	0.00212	CcSEcCtD
Metformin—NDUFA10—lymph node—skin cancer	0.000813	0.00151	CbGeAlD
Metformin—SLC22A3—nipple—skin cancer	0.000813	0.00151	CbGeAlD
Metformin—Ill-defined disorder—Dactinomycin—skin cancer	0.000813	0.00211	CcSEcCtD
Metformin—Liver function test abnormal—Docetaxel—skin cancer	0.000808	0.0021	CcSEcCtD
Metformin—NDUFC1—lymph node—skin cancer	0.000806	0.0015	CbGeAlD
Metformin—Vomiting—Vemurafenib—skin cancer	0.000804	0.00209	CcSEcCtD
Metformin—Chest pain—Bleomycin—skin cancer	0.0008	0.00208	CcSEcCtD
Metformin—Myalgia—Bleomycin—skin cancer	0.0008	0.00208	CcSEcCtD
Metformin—NDUFB2—lymph node—skin cancer	0.000799	0.00149	CbGeAlD
Metformin—Abdominal pain upper—Docetaxel—skin cancer	0.000799	0.00208	CcSEcCtD
Metformin—Rash—Vemurafenib—skin cancer	0.000798	0.00208	CcSEcCtD
Metformin—Dermatitis—Vemurafenib—skin cancer	0.000797	0.00207	CcSEcCtD
Metformin—NDUFC2—head—skin cancer	0.000795	0.00148	CbGeAlD
Metformin—NDUFAF1—lymph node—skin cancer	0.000793	0.00147	CbGeAlD
Metformin—Headache—Vemurafenib—skin cancer	0.000793	0.00206	CcSEcCtD
Metformin—Malnutrition—Temozolomide—skin cancer	0.000792	0.00206	CcSEcCtD
Metformin—Erythema—Temozolomide—skin cancer	0.000792	0.00206	CcSEcCtD
Metformin—Breast disorder—Docetaxel—skin cancer	0.000791	0.00206	CcSEcCtD
Metformin—Discomfort—Bleomycin—skin cancer	0.00079	0.00206	CcSEcCtD
Metformin—Malaise—Dactinomycin—skin cancer	0.00079	0.00206	CcSEcCtD
Metformin—Cramp muscle—Docetaxel—skin cancer	0.000788	0.00205	CcSEcCtD
Metformin—ND6—lymph node—skin cancer	0.000786	0.00146	CbGeAlD
Metformin—Nasopharyngitis—Docetaxel—skin cancer	0.000782	0.00204	CcSEcCtD
Metformin—NDUFB3—lymph node—skin cancer	0.00078	0.00145	CbGeAlD
Metformin—NDUFAF2—lymph node—skin cancer	0.00078	0.00145	CbGeAlD
Metformin—ND1—lymphoid tissue—skin cancer	0.000778	0.00145	CbGeAlD
Metformin—Dysgeusia—Temozolomide—skin cancer	0.000776	0.00202	CcSEcCtD
Metformin—Asthenia—Imiquimod—skin cancer	0.000774	0.00201	CcSEcCtD
Metformin—Oedema—Bleomycin—skin cancer	0.000766	0.00199	CcSEcCtD
Metformin—NDUFS2—head—skin cancer	0.000765	0.00142	CbGeAlD
Metformin—Pruritus—Imiquimod—skin cancer	0.000763	0.00199	CcSEcCtD
Metformin—NDUFA5—lymph node—skin cancer	0.000762	0.00142	CbGeAlD
Metformin—NDUFA11—lymph node—skin cancer	0.000762	0.00142	CbGeAlD
Metformin—Infection—Bleomycin—skin cancer	0.000761	0.00198	CcSEcCtD
Metformin—NDUFAF4—lymph node—skin cancer	0.000756	0.00141	CbGeAlD
Metformin—NDUFB6—lymph node—skin cancer	0.000756	0.00141	CbGeAlD
Metformin—NDUFS3—head—skin cancer	0.000755	0.0014	CbGeAlD
Metformin—Nausea—Vemurafenib—skin cancer	0.000751	0.00196	CcSEcCtD
Metformin—ND1—female reproductive system—skin cancer	0.000751	0.0014	CbGeAlD
Metformin—NDUFS1—lymph node—skin cancer	0.000751	0.0014	CbGeAlD
Metformin—Thrombocytopenia—Bleomycin—skin cancer	0.00075	0.00195	CcSEcCtD
Metformin—Vision blurred—Temozolomide—skin cancer	0.000747	0.00194	CcSEcCtD
Metformin—Myalgia—Dactinomycin—skin cancer	0.000746	0.00194	CcSEcCtD
Metformin—NDUFB10—lymph node—skin cancer	0.000745	0.00139	CbGeAlD
Metformin—Tremor—Temozolomide—skin cancer	0.000742	0.00193	CcSEcCtD
Metformin—NDUFA12—lymph node—skin cancer	0.00074	0.00138	CbGeAlD
Metformin—NDUFB7—lymph node—skin cancer	0.00074	0.00138	CbGeAlD
Metformin—Diarrhoea—Imiquimod—skin cancer	0.000738	0.00192	CcSEcCtD
Metformin—Discomfort—Dactinomycin—skin cancer	0.000737	0.00192	CcSEcCtD
Metformin—Angina pectoris—Docetaxel—skin cancer	0.000737	0.00192	CcSEcCtD
Metformin—Ill-defined disorder—Temozolomide—skin cancer	0.000735	0.00191	CcSEcCtD
Metformin—NDUFS8—lymph node—skin cancer	0.000735	0.00137	CbGeAlD
Metformin—NDUFB1—lymph node—skin cancer	0.000735	0.00137	CbGeAlD
Metformin—Anorexia—Bleomycin—skin cancer	0.000731	0.0019	CcSEcCtD
Metformin—Erythema—Fluorouracil—skin cancer	0.00073	0.0019	CcSEcCtD
Metformin—NDUFB5—lymph node—skin cancer	0.000725	0.00135	CbGeAlD
Metformin—NDUFA6—lymph node—skin cancer	0.000725	0.00135	CbGeAlD
Metformin—NDUFS4—lymph node—skin cancer	0.00072	0.00134	CbGeAlD
Metformin—Hypotension—Bleomycin—skin cancer	0.000716	0.00186	CcSEcCtD
Metformin—Oedema—Dactinomycin—skin cancer	0.000715	0.00186	CcSEcCtD
Metformin—Malaise—Temozolomide—skin cancer	0.000714	0.00186	CcSEcCtD
Metformin—Dizziness—Imiquimod—skin cancer	0.000713	0.00186	CcSEcCtD
Metformin—NDUFB4—lymph node—skin cancer	0.000711	0.00132	CbGeAlD
Metformin—Infection—Dactinomycin—skin cancer	0.00071	0.00185	CcSEcCtD
Metformin—Neutropenia—Docetaxel—skin cancer	0.000707	0.00184	CcSEcCtD
Metformin—NDUFAB1—lymph node—skin cancer	0.000706	0.00131	CbGeAlD
Metformin—NDUFA8—lymph node—skin cancer	0.000702	0.00131	CbGeAlD
Metformin—NDUFB9—lymph node—skin cancer	0.000702	0.00131	CbGeAlD
Metformin—Palpitations—Temozolomide—skin cancer	0.0007	0.00182	CcSEcCtD
Metformin—Thrombocytopenia—Dactinomycin—skin cancer	0.0007	0.00182	CcSEcCtD
Metformin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000698	0.00182	CcSEcCtD
Metformin—NDUFA4—lymph node—skin cancer	0.000698	0.0013	CbGeAlD
Metformin—NDUFV1—lymph node—skin cancer	0.000694	0.00129	CbGeAlD
Metformin—NDUFB11—lymph node—skin cancer	0.000694	0.00129	CbGeAlD
Metformin—NDUFB8—lymph node—skin cancer	0.00069	0.00128	CbGeAlD
Metformin—NDUFS5—lymph node—skin cancer	0.00069	0.00128	CbGeAlD
Metformin—Paraesthesia—Bleomycin—skin cancer	0.000688	0.00179	CcSEcCtD
Metformin—Vision blurred—Fluorouracil—skin cancer	0.000688	0.00179	CcSEcCtD
Metformin—Vomiting—Imiquimod—skin cancer	0.000686	0.00178	CcSEcCtD
Metformin—Hypertension—Temozolomide—skin cancer	0.000684	0.00178	CcSEcCtD
Metformin—Dyspnoea—Bleomycin—skin cancer	0.000683	0.00178	CcSEcCtD
Metformin—Anorexia—Dactinomycin—skin cancer	0.000681	0.00177	CcSEcCtD
Metformin—Rash—Imiquimod—skin cancer	0.00068	0.00177	CcSEcCtD
Metformin—Dermatitis—Imiquimod—skin cancer	0.00068	0.00177	CcSEcCtD
Metformin—Headache—Imiquimod—skin cancer	0.000676	0.00176	CcSEcCtD
Metformin—Myalgia—Temozolomide—skin cancer	0.000674	0.00175	CcSEcCtD
Metformin—Infestation NOS—Docetaxel—skin cancer	0.000674	0.00175	CcSEcCtD
Metformin—Infestation—Docetaxel—skin cancer	0.000674	0.00175	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00067	0.00174	CcSEcCtD
Metformin—Discomfort—Temozolomide—skin cancer	0.000666	0.00173	CcSEcCtD
Metformin—Decreased appetite—Bleomycin—skin cancer	0.000666	0.00173	CcSEcCtD
Metformin—Neuropathy peripheral—Docetaxel—skin cancer	0.000661	0.00172	CcSEcCtD
Metformin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000651	0.00169	CcSEcCtD
Metformin—Oedema—Temozolomide—skin cancer	0.000647	0.00168	CcSEcCtD
Metformin—NDUFS7—lymph node—skin cancer	0.000646	0.0012	CbGeAlD
Metformin—Infection—Temozolomide—skin cancer	0.000642	0.00167	CcSEcCtD
Metformin—Nausea—Imiquimod—skin cancer	0.000641	0.00167	CcSEcCtD
Metformin—Hepatobiliary disease—Docetaxel—skin cancer	0.000638	0.00166	CcSEcCtD
Metformin—Nervous system disorder—Temozolomide—skin cancer	0.000634	0.00165	CcSEcCtD
Metformin—Thrombocytopenia—Temozolomide—skin cancer	0.000633	0.00165	CcSEcCtD
Metformin—Feeling abnormal—Bleomycin—skin cancer	0.000632	0.00164	CcSEcCtD
Metformin—Skin disorder—Temozolomide—skin cancer	0.000628	0.00163	CcSEcCtD
Metformin—ND1—head—skin cancer	0.000627	0.00117	CbGeAlD
Metformin—Hyperhidrosis—Temozolomide—skin cancer	0.000625	0.00163	CcSEcCtD
Metformin—Myalgia—Fluorouracil—skin cancer	0.000621	0.00162	CcSEcCtD
Metformin—Chest pain—Fluorouracil—skin cancer	0.000621	0.00162	CcSEcCtD
Metformin—Decreased appetite—Dactinomycin—skin cancer	0.000621	0.00162	CcSEcCtD
Metformin—Fatigue—Dactinomycin—skin cancer	0.000616	0.0016	CcSEcCtD
Metformin—Anorexia—Temozolomide—skin cancer	0.000616	0.0016	CcSEcCtD
Metformin—Discomfort—Fluorouracil—skin cancer	0.000614	0.0016	CcSEcCtD
Metformin—Urticaria—Bleomycin—skin cancer	0.000609	0.00158	CcSEcCtD
Metformin—Rhinitis—Docetaxel—skin cancer	0.000607	0.00158	CcSEcCtD
Metformin—Hepatitis—Docetaxel—skin cancer	0.000605	0.00157	CcSEcCtD
Metformin—Hypoaesthesia—Docetaxel—skin cancer	0.000602	0.00157	CcSEcCtD
Metformin—Oedema peripheral—Docetaxel—skin cancer	0.000596	0.00155	CcSEcCtD
Metformin—Oedema—Fluorouracil—skin cancer	0.000596	0.00155	CcSEcCtD
Metformin—SLC47A1—mammalian vulva—skin cancer	0.000596	0.00111	CbGeAlD
Metformin—Connective tissue disorder—Docetaxel—skin cancer	0.000595	0.00155	CcSEcCtD
Metformin—Infection—Fluorouracil—skin cancer	0.000592	0.00154	CcSEcCtD
Metformin—PRKAB1—lymph node—skin cancer	0.000591	0.0011	CbGeAlD
Metformin—Feeling abnormal—Dactinomycin—skin cancer	0.000589	0.00153	CcSEcCtD
Metformin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000589	0.00153	CcSEcCtD
Metformin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000585	0.00152	CcSEcCtD
Metformin—Nervous system disorder—Fluorouracil—skin cancer	0.000584	0.00152	CcSEcCtD
Metformin—Thrombocytopenia—Fluorouracil—skin cancer	0.000583	0.00152	CcSEcCtD
Metformin—Paraesthesia—Temozolomide—skin cancer	0.000581	0.00151	CcSEcCtD
Metformin—SLC22A3—connective tissue—skin cancer	0.000577	0.00107	CbGeAlD
Metformin—Dyspnoea—Temozolomide—skin cancer	0.000576	0.0015	CcSEcCtD
Metformin—Somnolence—Temozolomide—skin cancer	0.000575	0.0015	CcSEcCtD
Metformin—Dyspepsia—Temozolomide—skin cancer	0.000569	0.00148	CcSEcCtD
Metformin—Anorexia—Fluorouracil—skin cancer	0.000568	0.00148	CcSEcCtD
Metformin—Eye disorder—Docetaxel—skin cancer	0.000566	0.00147	CcSEcCtD
Metformin—Abdominal pain—Dactinomycin—skin cancer	0.000565	0.00147	CcSEcCtD
Metformin—Decreased appetite—Temozolomide—skin cancer	0.000562	0.00146	CcSEcCtD
Metformin—Flushing—Docetaxel—skin cancer	0.000562	0.00146	CcSEcCtD
Metformin—Cardiac disorder—Docetaxel—skin cancer	0.000562	0.00146	CcSEcCtD
Metformin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000558	0.00145	CcSEcCtD
Metformin—Fatigue—Temozolomide—skin cancer	0.000557	0.00145	CcSEcCtD
Metformin—NDUFC2—lymph node—skin cancer	0.000557	0.00104	CbGeAlD
Metformin—Hypotension—Fluorouracil—skin cancer	0.000557	0.00145	CcSEcCtD
Metformin—Constipation—Temozolomide—skin cancer	0.000553	0.00144	CcSEcCtD
Metformin—Asthenia—Bleomycin—skin cancer	0.00055	0.00143	CcSEcCtD
Metformin—Angiopathy—Docetaxel—skin cancer	0.000549	0.00143	CcSEcCtD
Metformin—Immune system disorder—Docetaxel—skin cancer	0.000547	0.00142	CcSEcCtD
Metformin—Mediastinal disorder—Docetaxel—skin cancer	0.000545	0.00142	CcSEcCtD
Metformin—Chills—Docetaxel—skin cancer	0.000543	0.00141	CcSEcCtD
Metformin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000543	0.00141	CcSEcCtD
Metformin—Pruritus—Bleomycin—skin cancer	0.000542	0.00141	CcSEcCtD
Metformin—NDUFS2—lymph node—skin cancer	0.000535	0.000996	CbGeAlD
Metformin—Paraesthesia—Fluorouracil—skin cancer	0.000535	0.00139	CcSEcCtD
Metformin—Feeling abnormal—Temozolomide—skin cancer	0.000533	0.00139	CcSEcCtD
Metformin—Dyspnoea—Fluorouracil—skin cancer	0.000531	0.00138	CcSEcCtD
Metformin—Somnolence—Fluorouracil—skin cancer	0.00053	0.00138	CcSEcCtD
Metformin—NDUFS3—lymph node—skin cancer	0.000529	0.000983	CbGeAlD
Metformin—Gastrointestinal pain—Temozolomide—skin cancer	0.000529	0.00138	CcSEcCtD
Metformin—Malnutrition—Docetaxel—skin cancer	0.000527	0.00137	CcSEcCtD
Metformin—Erythema—Docetaxel—skin cancer	0.000527	0.00137	CcSEcCtD
Metformin—Dyspepsia—Fluorouracil—skin cancer	0.000524	0.00136	CcSEcCtD
Metformin—Decreased appetite—Fluorouracil—skin cancer	0.000518	0.00135	CcSEcCtD
Metformin—Dysgeusia—Docetaxel—skin cancer	0.000516	0.00134	CcSEcCtD
Metformin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000514	0.00134	CcSEcCtD
Metformin—Urticaria—Temozolomide—skin cancer	0.000514	0.00134	CcSEcCtD
Metformin—Asthenia—Dactinomycin—skin cancer	0.000513	0.00133	CcSEcCtD
Metformin—Abdominal pain—Temozolomide—skin cancer	0.000511	0.00133	CcSEcCtD
Metformin—SLC47A1—female reproductive system—skin cancer	0.00051	0.000948	CbGeAlD
Metformin—Muscle spasms—Docetaxel—skin cancer	0.000507	0.00132	CcSEcCtD
Metformin—Feeling abnormal—Fluorouracil—skin cancer	0.000491	0.00128	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—skin cancer	0.000489	0.00127	CcSEcCtD
Metformin—Vomiting—Bleomycin—skin cancer	0.000487	0.00127	CcSEcCtD
Metformin—Rash—Bleomycin—skin cancer	0.000483	0.00126	CcSEcCtD
Metformin—Dermatitis—Bleomycin—skin cancer	0.000483	0.00126	CcSEcCtD
Metformin—SLC22A3—mammalian vulva—skin cancer	0.000475	0.000883	CbGeAlD
Metformin—Urticaria—Fluorouracil—skin cancer	0.000473	0.00123	CcSEcCtD
Metformin—Syncope—Docetaxel—skin cancer	0.000472	0.00123	CcSEcCtD
Metformin—Palpitations—Docetaxel—skin cancer	0.000466	0.00121	CcSEcCtD
Metformin—Asthenia—Temozolomide—skin cancer	0.000464	0.00121	CcSEcCtD
Metformin—Loss of consciousness—Docetaxel—skin cancer	0.000463	0.0012	CcSEcCtD
Metformin—Pruritus—Temozolomide—skin cancer	0.000457	0.00119	CcSEcCtD
Metformin—Nausea—Bleomycin—skin cancer	0.000455	0.00118	CcSEcCtD
Metformin—Hypertension—Docetaxel—skin cancer	0.000455	0.00118	CcSEcCtD
Metformin—Vomiting—Dactinomycin—skin cancer	0.000455	0.00118	CcSEcCtD
Metformin—Rash—Dactinomycin—skin cancer	0.000451	0.00117	CcSEcCtD
Metformin—Myalgia—Docetaxel—skin cancer	0.000449	0.00117	CcSEcCtD
Metformin—Chest pain—Docetaxel—skin cancer	0.000449	0.00117	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000445	0.00116	CcSEcCtD
Metformin—Diarrhoea—Temozolomide—skin cancer	0.000442	0.00115	CcSEcCtD
Metformin—ND1—lymph node—skin cancer	0.000439	0.000817	CbGeAlD
Metformin—Oedema—Docetaxel—skin cancer	0.00043	0.00112	CcSEcCtD
Metformin—Dizziness—Temozolomide—skin cancer	0.000428	0.00111	CcSEcCtD
Metformin—Infection—Docetaxel—skin cancer	0.000427	0.00111	CcSEcCtD
Metformin—SLC47A1—head—skin cancer	0.000426	0.000792	CbGeAlD
Metformin—Nausea—Dactinomycin—skin cancer	0.000425	0.0011	CcSEcCtD
Metformin—Shock—Docetaxel—skin cancer	0.000423	0.0011	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—skin cancer	0.000422	0.0011	CcSEcCtD
Metformin—Pruritus—Fluorouracil—skin cancer	0.000421	0.0011	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—skin cancer	0.000421	0.0011	CcSEcCtD
Metformin—Skin disorder—Docetaxel—skin cancer	0.000418	0.00109	CcSEcCtD
Metformin—Vomiting—Temozolomide—skin cancer	0.000411	0.00107	CcSEcCtD
Metformin—Anorexia—Docetaxel—skin cancer	0.00041	0.00107	CcSEcCtD
Metformin—Rash—Temozolomide—skin cancer	0.000408	0.00106	CcSEcCtD
Metformin—Diarrhoea—Fluorouracil—skin cancer	0.000408	0.00106	CcSEcCtD
Metformin—Dermatitis—Temozolomide—skin cancer	0.000407	0.00106	CcSEcCtD
Metformin—SLC22A3—female reproductive system—skin cancer	0.000407	0.000756	CbGeAlD
Metformin—Headache—Temozolomide—skin cancer	0.000405	0.00105	CcSEcCtD
Metformin—Hypotension—Docetaxel—skin cancer	0.000402	0.00105	CcSEcCtD
Metformin—Dizziness—Fluorouracil—skin cancer	0.000394	0.00102	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000392	0.00102	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—skin cancer	0.000386	0.001	CcSEcCtD
Metformin—Nausea—Temozolomide—skin cancer	0.000384	0.000999	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—skin cancer	0.000383	0.000997	CcSEcCtD
Metformin—Somnolence—Docetaxel—skin cancer	0.000382	0.000994	CcSEcCtD
Metformin—Vomiting—Fluorouracil—skin cancer	0.000379	0.000985	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—skin cancer	0.000378	0.000985	CcSEcCtD
Metformin—Rash—Fluorouracil—skin cancer	0.000376	0.000977	CcSEcCtD
Metformin—Dermatitis—Fluorouracil—skin cancer	0.000375	0.000976	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—skin cancer	0.000374	0.000972	CcSEcCtD
Metformin—Headache—Fluorouracil—skin cancer	0.000373	0.000971	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000371	0.000966	CcSEcCtD
Metformin—Fatigue—Docetaxel—skin cancer	0.000371	0.000964	CcSEcCtD
Metformin—Constipation—Docetaxel—skin cancer	0.000368	0.000957	CcSEcCtD
Metformin—SLC22A1—head—skin cancer	0.000356	0.000661	CbGeAlD
Metformin—Feeling abnormal—Docetaxel—skin cancer	0.000354	0.000922	CcSEcCtD
Metformin—Nausea—Fluorouracil—skin cancer	0.000354	0.000921	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—skin cancer	0.000352	0.000915	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—skin cancer	0.00034	0.000884	CcSEcCtD
Metformin—SLC22A3—head—skin cancer	0.00034	0.000632	CbGeAlD
Metformin—Asthenia—Docetaxel—skin cancer	0.000308	0.000803	CcSEcCtD
Metformin—Pruritus—Docetaxel—skin cancer	0.000304	0.000791	CcSEcCtD
Metformin—NDUFA7—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND4L—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND6—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND2—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND4—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND3—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—ND5—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—CSPG4—skin cancer	0.000299	0.00384	CbGpPWpGaD
Metformin—SLC47A1—lymph node—skin cancer	0.000298	0.000555	CbGeAlD
Metformin—Diarrhoea—Docetaxel—skin cancer	0.000294	0.000765	CcSEcCtD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000291	0.00374	CbGpPWpGaD
Metformin—Dizziness—Docetaxel—skin cancer	0.000284	0.00074	CcSEcCtD
Metformin—NDUFS7—Metabolism—PLIN2—skin cancer	0.000281	0.00361	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PLIN2—skin cancer	0.000281	0.00361	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PLIN2—skin cancer	0.000281	0.00361	CbGpPWpGaD
Metformin—Vomiting—Docetaxel—skin cancer	0.000273	0.000711	CcSEcCtD
Metformin—Rash—Docetaxel—skin cancer	0.000271	0.000705	CcSEcCtD
Metformin—Dermatitis—Docetaxel—skin cancer	0.000271	0.000705	CcSEcCtD
Metformin—Headache—Docetaxel—skin cancer	0.000269	0.000701	CcSEcCtD
Metformin—NDUFV3—Metabolism—CSPG4—skin cancer	0.000267	0.00342	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PLIN2—skin cancer	0.000265	0.0034	CbGpPWpGaD
Metformin—Nausea—Docetaxel—skin cancer	0.000255	0.000664	CcSEcCtD
Metformin—PRKAB1—IRS-mediated signalling—NRAS—skin cancer	0.000255	0.00328	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—NRAS—skin cancer	0.000248	0.00319	CbGpPWpGaD
Metformin—NDUFA13—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000247	0.00318	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—NRAS—skin cancer	0.000246	0.00316	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—NRAS—skin cancer	0.00024	0.00308	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—NRAS—skin cancer	0.00024	0.00308	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—ENO2—skin cancer	0.000239	0.00307	CbGpPWpGaD
Metformin—SLC22A3—lymph node—skin cancer	0.000238	0.000442	CbGeAlD
Metformin—PRKAB1—AMPK Signaling—TP53—skin cancer	0.000231	0.00296	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CSPG4—skin cancer	0.000227	0.00291	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CSPG4—skin cancer	0.000227	0.00291	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CSPG4—skin cancer	0.000227	0.00291	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—KRAS—skin cancer	0.00022	0.00282	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—ENO2—skin cancer	0.000219	0.00281	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—ENO2—skin cancer	0.000219	0.00281	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—ENO2—skin cancer	0.000219	0.00281	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—ENO2—skin cancer	0.000219	0.00281	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—KRAS—skin cancer	0.000214	0.00274	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CSPG4—skin cancer	0.000213	0.00274	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—KRAS—skin cancer	0.000212	0.00272	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000211	0.00271	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—KRAS—skin cancer	0.000206	0.00265	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—KRAS—skin cancer	0.000206	0.00265	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND4—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND2—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND5—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND3—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND4L—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—ND6—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—ENO2—skin cancer	0.000203	0.00261	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—NRAS—skin cancer	0.000199	0.00256	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000197	0.00253	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—HRAS—skin cancer	0.000187	0.0024	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—HRAS—skin cancer	0.000182	0.00233	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—ENO2—skin cancer	0.000181	0.00233	CbGpPWpGaD
Metformin—ND1—Metabolism—PLIN2—skin cancer	0.000181	0.00233	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—HRAS—skin cancer	0.00018	0.00231	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—IL6—skin cancer	0.000179	0.0023	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—HRAS—skin cancer	0.000175	0.00225	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—HRAS—skin cancer	0.000175	0.00225	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—IL6—skin cancer	0.000174	0.00223	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—IL6—skin cancer	0.000172	0.00221	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—KRAS—skin cancer	0.000171	0.0022	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000171	0.0022	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—IL6—skin cancer	0.000168	0.00215	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—IL6—skin cancer	0.000168	0.00215	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ENO2—skin cancer	0.000154	0.00198	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ENO2—skin cancer	0.000154	0.00198	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ENO2—skin cancer	0.000154	0.00198	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTCH2—skin cancer	0.000149	0.00191	CbGpPWpGaD
Metformin—ND1—Metabolism—CSPG4—skin cancer	0.000146	0.00188	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—HRAS—skin cancer	0.000146	0.00187	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ENO2—skin cancer	0.000145	0.00186	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—IL6—skin cancer	0.000139	0.00179	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—ERCC2—skin cancer	0.000139	0.00178	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—TP53—skin cancer	0.000131	0.00168	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—ERCC2—skin cancer	0.000127	0.00163	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—ERCC2—skin cancer	0.000127	0.00163	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—ERCC2—skin cancer	0.000127	0.00163	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—ERCC2—skin cancer	0.000127	0.00163	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND6—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND5—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND4—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND4L—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND3—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—ND2—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—ERCC2—skin cancer	0.000118	0.00152	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GLI2—skin cancer	0.000113	0.00145	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MC1R—skin cancer	0.000108	0.00138	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000107	0.00138	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GLI1—skin cancer	0.000106	0.00136	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—ERCC2—skin cancer	0.000105	0.00135	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SUFU—skin cancer	0.000101	0.00129	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.99e-05	0.00128	CbGpPWpGaD
Metformin—ND1—Metabolism—ENO2—skin cancer	9.93e-05	0.00128	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ERCC2—skin cancer	8.95e-05	0.00115	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ERCC2—skin cancer	8.95e-05	0.00115	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ERCC2—skin cancer	8.95e-05	0.00115	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PLIN2—skin cancer	8.45e-05	0.00108	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ERCC2—skin cancer	8.42e-05	0.00108	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTGS2—skin cancer	8.33e-05	0.00107	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SHH—skin cancer	7.67e-05	0.000984	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTGS2—skin cancer	7.62e-05	0.000979	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTGS2—skin cancer	7.62e-05	0.000979	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTGS2—skin cancer	7.62e-05	0.000979	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTGS2—skin cancer	7.62e-05	0.000979	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RASA1—skin cancer	7.62e-05	0.000978	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTCH1—skin cancer	7.27e-05	0.000933	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SMO—skin cancer	7.27e-05	0.000933	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—skin cancer	7.08e-05	0.00091	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTGER4—skin cancer	7.07e-05	0.000908	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CSPG4—skin cancer	6.81e-05	0.000874	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	6.49e-05	0.000833	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—skin cancer	6.31e-05	0.000811	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FOXO4—skin cancer	6.25e-05	0.000802	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	6.05e-05	0.000776	CbGpPWpGaD
Metformin—ND1—Metabolism—ERCC2—skin cancer	5.77e-05	0.000741	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—skin cancer	5.37e-05	0.000689	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—skin cancer	5.37e-05	0.000689	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—skin cancer	5.37e-05	0.000689	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLIN2—skin cancer	5.3e-05	0.00068	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—skin cancer	5.05e-05	0.000648	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—skin cancer	4.97e-05	0.000638	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLIN2—skin cancer	4.94e-05	0.000634	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—skin cancer	4.63e-05	0.000595	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO2—skin cancer	4.63e-05	0.000594	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CSPG4—skin cancer	4.27e-05	0.000548	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—skin cancer	4.17e-05	0.000536	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CSPG4—skin cancer	3.98e-05	0.000511	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—skin cancer	3.46e-05	0.000444	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—skin cancer	3.31e-05	0.000424	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	2.98e-05	0.000383	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—skin cancer	2.9e-05	0.000373	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	2.78e-05	0.000357	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—skin cancer	2.71e-05	0.000347	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—skin cancer	2.69e-05	0.000345	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—skin cancer	2.29e-05	0.000293	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—skin cancer	2.13e-05	0.000274	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—skin cancer	2.08e-05	0.000267	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—skin cancer	1.79e-05	0.00023	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—skin cancer	1.69e-05	0.000217	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—skin cancer	1.61e-05	0.000207	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—skin cancer	1.59e-05	0.000204	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—skin cancer	1.57e-05	0.000202	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—skin cancer	1.52e-05	0.000195	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—skin cancer	1.45e-05	0.000187	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—skin cancer	1.01e-05	0.00013	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—skin cancer	9.42e-06	0.000121	CbGpPWpGaD
